Uveal melanoma, which primarily affects Caucasian patients, is the most common primary intraocular tumor in adults2 that most ...

Uveal melanoma, or ocular melanoma, is a cancer that happens inside your eyeball. It’s rare. Just 7 out of every 1 million people get it each year. But it’s also the most common eye cancer for ...

After you’ve been diagnosed with uveal melanoma (also called ocular melanoma), it’s important to take note of your health to watch for signs that the cancer may have spread (metastasized ...

The summer of 2023 saw the approval of a new treatment option for certain patients with uveal melanoma, a form of cancer that begins in the eye and remains a challenge to treat. Richard Staines ...

The FDA granted Breakthrough Therapy designation to IDE196 for the neoadjuvant treatment of primary uveal melanoma when ...

The rare ocular, acral and mucosal melanoma subtypes have no known environmental risk factors, making early detection and ...

Patient-derived organoids can be established from uveal melanoma tumors. Credit: Investigative Ophthalmology & Visual Science (2024). DOI: 10.1167/iovs.65.13.60 ...

A phase 3 trial plans to further assess neoadjuvant darovasertib for the potential treatment of patients with primary uveal ...

iOnctura has dosed the first subject in the open-label Phase II OCULE-01 trial of oral roginolisib in individuals with rare eye cancer, metastatic uveal melanoma (UM). The randomised, parallel-arm ...

Investigators studied the relationship between Fitzpatrick skin type and the characteristics and outcomes associated with 2 types of ocular melanoma.

"[Money raised] for uveal melanoma research is a powerful step toward advancing much-needed treatments. While there is still no cure for this rare and aggressive disease, the generosity of this ...

iOnctura has dosed the first subject in the open-label Phase II OCULE-01 trial of oral roginolisib in individuals with rare eye cancer, metastatic uveal melanoma (UM). The randomised, parallel-arm ...